Go to Top



Thrombosis Canada Announces New Executive Director

Thrombosis Canada, the voice of vascular medicine in Canada since 1991, is pleased to announce the hiring of David Airdrie as its new Executive Director, effective December 1, 2016. This is a new chapter for Thrombosis Canada as it grows and evolves to deliver on its mission to further education, knowledge translation and research in the prevention and treatment of

Read More

Idarucizumab Approved by Health Canada as Dabigatran Antidote

Idarucizumab  is now available as an antidote for dabigatran. Please refer to the highlighted clinical guides, clinical tools, and resources below for further information.  Please note, that Thrombosis Canada in partnership with Think Research has developed a Bleed Management patient order set. Clinical Guides Dabigatran New/Novel Oral Anticoagulants (NOACs): Management of Bleeding Clinical Tools We have also updated our Perioperative Anticoagulant

Read More

Anticoagulation Forum’s 14th National Conference on Antithrombotic Therapy – April 20-22, 2017

What should I know about drug interactions and DOACs? How are anticoagulation clinics evolving? What makes an ER patient a good candidate for a DOAC? What's the balance between anticoagulants, ablation and implantable devices? These are just a few of the questions that will be addressed at AC Forum's national conference, April 20-22, 2017. The 3-day symposium will bring together

Read More